Finance

Beta
Lists
090430:KRX
Amorepacific Corp
â‚©112,000.00
+6.67%
(+7,000.00) 1D
Jun 9, 3:30:25 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 090430...
Open
â‚©105,900
High
â‚©114,400
Low
â‚©105,500
Mkt. cap
6.95T
Avg. vol.
337.00K
Volume
438.23K
Dividend
1.11%
Quarterly dividend
â‚©310
Ex-dividend date
Mar 30, 2026
P/E ratio
33.08
52-wk high
â‚©169,000
52-wk low
â‚©102,100
EPS
â‚©3,385
Shares outstanding
58.49M
No. of employees
4K
Open
â‚©105,900
High
â‚©114,400
Low
â‚©105,500
Mkt. cap
6.95T
Avg. vol.
337.00K
Volume
438.23K
Dividend
1.11%
Quarterly dividend
â‚©310
Ex-dividend date
Mar 30, 2026
P/E ratio
33.08
52-wk high
â‚©169,000
52-wk low
â‚©102,100
EPS
â‚©3,385
Shares outstanding
58.49M
No. of employees
4K
News stories
From sources across the web
Profile
Amorepacific Corporation is a South Korean beauty and cosmetics chaebol, operating more than 30 beauty, personal care, and health brands including Sulwhasoo, Laneige, Etude, Aestura, Cosrx, AP Beauty, and Innisfree. The firm was founded in 1945 by Sungwhan Suh and currently managed by Kyungbae Suh, the son of the founder. It is the largest cosmetics company in South Korea and one of the ten largest cosmetics companies in the world. Wikipedia
About Amorepacific Corp
CEOKim Seung-hwan | Suh Kyung-Bae
Employees4.37K
FoundedSep 1945
Headquarters-
SectorPersonal care products
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.01T
1.02T
1.16T
1.14T
Cost of goods sold
275.14B
286.65B
316.71B
306.08B
Cost of revenue
275.14B
286.65B
316.71B
306.08B
Research and development expenses
27.73B
24.42B
26.25B
24.88B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
570.68B
555.58B
711.68B
621.91B
Operating expense
656.22B
638.37B
794.13B
702.97B
Total operating expenses
931.36B
925.02B
1.11T
1.01T
Operating income
73.66B
91.89B
52.55B
126.71B
Other non operating income
-21.27B
6.90B
-20.61B
26.26B
EBT including unusual items
52.42B
98.83B
51.63B
152.73B
EBT excluding unusual items
52.39B
98.79B
19.21B
152.97B
Income tax expense
14.79B
30.59B
29.13B
39.74B
Effective tax rate
28.21%
30.95%
56.43%
26.02%
Other operating expenses
6.17B
7.56B
8.01B
7.93B
Net income
35.78B
66.01B
23.10B
108.54B
Net profit margin
3.56%
6.49%
1.99%
9.56%
Earnings per share
519.00
958.00
336.00
1.57K
Interest and investment income
-
-
13.87B
-
Interest expense
-
-
-22.45B
-
Net interest expenses
-
-
-8.59B
-
Depreciation and amortization charges
51.65B
50.81B
48.18B
48.26B
EBITDA
141.84B
158.84B
117.08B
190.95B
Gain or loss from assets sale
892.00M
60.00M
-120.52M
-6.68B
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more